Related Experiment Video
Updated: Dec 23, 2025

09:57
Isolation and Analysis of Traceable and Functionalized Extracellular Vesicles from the Plasma and Solid Tissues
Published on: October 17, 2022
2.6K
Autophagy Driven Extracellular Vesicles in the Leukaemic Microenvironment
Rebecca H Horton1, Tom Wileman1, Stuart A Rushworth1
1Norwich Medical School, University of East Anglia, Norwich Research Park, Norwich, NR4 7UQ, United Kingdom.
Current Cancer Drug Targets
|April 29, 2020
Summary
Leukaemias are deadly blood cancers. This review explores how targeting cellular mechanisms like autophagy and extracellular vesicles could offer new therapeutic strategies for leukaemia and other diseases.
Area of Science:
- Hematology
- Cellular Biology
- Cancer Research
Background:
- Leukaemias are a diverse group of blood cancers causing significant mortality.
- Despite advances, many leukaemia subtypes lack targeted therapies, relying on cytotoxic drugs and bone marrow transplants.
- Projected increases in leukaemia deaths highlight the urgent need for novel treatment strategies.
Purpose of the Study:
- To review cellular mechanisms, specifically autophagy and extracellular vesicles, for potential therapeutic exploitation in leukaemia.
- To explore how dysregulation of these mechanisms impacts the leukaemic microenvironment and disease progression.
- To briefly examine the role of these mechanisms in other conditions like autoimmunity, inflammation, and degenerative diseases.
Main Methods:
- Literature review focusing on autophagy and extracellular vesicles in the context of leukaemia.
- Analysis of how these cellular processes influence the leukaemic microenvironment.
- Exploration of potential therapeutic targets within these mechanisms.
Main Results:
- Autophagy and extracellular vesicles play a dual role in the leukaemic microenvironment, potentially promoting disease propagation.
- Dysregulation of these pathways offers avenues for targeted therapeutic intervention.
- These mechanisms are also implicated in other non-malignant diseases.
Conclusions:
- Targeting autophagy and extracellular vesicles presents a promising strategy for developing novel leukaemia therapies.
- Understanding these cellular mechanisms is crucial for advancing cancer treatment and managing related diseases.
- Further research into these pathways could lead to more specific and effective treatments for leukaemias and other inflammatory conditions.
More Related Videos
Related Concept Videos
Delivery Pathways to the Lysosome
8.6K
Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
8.6K
Autophagy
5.5K
Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
5.5K
Intralumenal Vesicles and Multivesicular Bodies
4.5K
Intraluminal vesicles (ILVs) are small vesicles 50-80 nm in diameter formed during the maturation of early endosomes. A specialized endosome containing numerous ILVs is called a multivesicular body (MVB). ILVs contain internalized molecules such as antigens, nucleic acids, proteins, and metabolites. Some of these molecules are released from the MVBs inside exosomes and are transported to other cells. Other MVBs contain molecules that are retained in the ILVs and are later degraded within the...
4.5K
Overview of Exosomes
3.4K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
3.4K
The Tumor Microenvironment
7.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.5K

